{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:12:43Z","timestamp":1794978763631,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1053\/j.gastro.2018.01.027","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T08:55:10Z","timestamp":1517388910000},"page":"1635-1646.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":384,"title":["Bi-directionality of Brain\u2013Gut Interactions in Patients With Inflammatory Bowel Disease"],"prefix":"10.1053","volume":"154","author":[{"given":"David J.","family":"Gracie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth A.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. John","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2018.01.027_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/apt.12669","article-title":"The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study","volume":"39","author":"Panara","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.01.027_bib3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","article-title":"Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study","volume":"66","author":"Mittermaier","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1053\/j.gastro.2018.01.027_bib6","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/ibd.22916","article-title":"Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib7","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","article-title":"The brain\u2014gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study","volume":"61","author":"Koloski","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.01.027_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/apt.13738","article-title":"Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study","volume":"44","author":"Koloski","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.01.027_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1053\/j.gastro.2010.06.063","article-title":"Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice","volume":"139","author":"Bercik","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1053\/j.gastro.2009.02.069","article-title":"Reactivation of inflammatory bowel disease in a mouse model of depression","volume":"136","author":"Ghia","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib11","first-page":"2209","article-title":"Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression","volume":"118","author":"Ghia","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2018.01.027_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4292\/wjgpt.v3.i6.83","article-title":"Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-kappaB\/nitric oxide pathway and inhibition of cytokine production: A hypothesis","volume":"3","author":"Rahimi","year":"2012","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.01.027_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/nmo.12792","article-title":"Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study","volume":"28","author":"Bonaz","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2018.01.027_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.gastro.2006.05.017","article-title":"The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis","volume":"131","author":"Mawdsley","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/ibd.21846","article-title":"Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ibd.21098","article-title":"Does psychological counseling alter the natural history of inflammatory bowel disease?","volume":"16","author":"Wahed","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2468-1253(16)30206-0","article-title":"Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis","volume":"2","author":"Gracie","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.01.027_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/apt.12449","article-title":"Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis","volume":"38","author":"Keefer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.01.027_bib19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1037\/ccp0000227","article-title":"Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: a multicenter randomized controlled trial","volume":"85","author":"Bennebroek Evertsz","year":"2017","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1053\/j.gastro.2018.01.027_bib20","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1097\/MIB.0000000000000568","article-title":"The effect of breathing, movement, and meditation on psychological and physical symptoms and inflammatory biomarkers in inflammatory bowel disease: a randomized controlled trial","volume":"21","author":"Gerbarg","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cgh.2016.05.012","article-title":"Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease","volume":"15","author":"Gracie","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.01.027_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/ajg.2016.59","article-title":"Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease","volume":"111","author":"Gracie","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.01.027_bib24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"},{"key":"10.1053\/j.gastro.2018.01.027_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A\u00a0simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2018.01.027_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A\u00a0simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.01.027_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2010.01.001","article-title":"Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity","volume":"8","author":"Vermeire","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.01.027_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/00365520310000654","article-title":"Defining relapse of ulcerative colitis using a symptom-based activity index","volume":"38","author":"Jowett","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1053\/j.gastro.2018.01.027_bib31","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.crohns.2014.07.009","article-title":"How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals","volume":"8","author":"Mikocka-Walus","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.01.027_bib32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/ibd.22850","article-title":"An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation","volume":"18","author":"Mikocka-Walus","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MIB.0000000000001040","article-title":"Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease","volume":"23","author":"Sexton","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.crohns.2013.02.014","article-title":"Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion","volume":"7","author":"Rogler","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.01.027_bib35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2015.147","article-title":"The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease","volume":"110","author":"Targownik","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib36","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D'Haens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib37","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PSY.0b013e3182545d47","article-title":"Revealing causal heterogeneity using time series analysis of ambulatory assessments: application to the association between depression and physical activity after myocardial infarction","volume":"74","author":"Rosmalen","year":"2012","journal-title":"Psychosom Med"},{"key":"10.1053\/j.gastro.2018.01.027_bib39","unstructured":"National Institute for Health and Care Excellence. Infliximab and adalimumab for the treatment of Crohn's disease. https:\/\/www.nice.org.uk\/guidance\/ta187\/resources\/infliximab-and-adalimumab-for-the-treatment-of-crohns-disease-pdf-82598501180869. Published 2010. Accessed September 12,\u00a02017."},{"key":"10.1053\/j.gastro.2018.01.027_bib40","unstructured":"National Institute for Health and Care Excellence. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy. https:\/\/www.nice.org.uk\/guidance\/ta329\/resources\/infliximab-adalimumab-and-golimumab-for-treating-moderately-to-severely-active-ulcerative-colitis-after-the-failure-of-conventional-therapy-pdf-82602495307717. Published 2015. Accessed September 12,\u00a02017."},{"key":"10.1053\/j.gastro.2018.01.027_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpsychores.2011.12.003","article-title":"No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS)","volume":"72","author":"Coyne","year":"2012","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1053\/j.gastro.2018.01.027_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbi.2016.03.004","article-title":"Associations of low grade inflammation and endothelial dysfunction with depression\u2014The Maastricht Study","volume":"56","author":"van Dooren","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1053\/j.gastro.2018.01.027_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2036.2005.02535.x","article-title":"The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab","volume":"22","author":"Persoons","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.01.027_bib44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.01.027_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ajg.2016.98","article-title":"Association between affective-cognitive symptoms of depression and exacerbation of crohn's disease","volume":"111","author":"Gaines","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1023\/B:DDAS.0000020509.23162.cc","article-title":"Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity","volume":"49","author":"Mardini","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2018.01.027_bib47","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/ibd.20511","article-title":"Longitudinal study of\u00a0quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory\u00a0bowel disease","volume":"14","author":"Lix","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/00365529609010354","article-title":"A\u00a0prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease","volume":"31","author":"Porcelli","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib49","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1572-0241.2000.02012.x","article-title":"Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission","volume":"95","author":"Levenstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.01.027_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"Bitton","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.01.027_bib52","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1097\/MIB.0b013e3182a192ba","article-title":"Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study","volume":"19","author":"Langhorst","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MIB.0000000000001059","article-title":"Antidepressants in inflammatory bowel disease: a systematic review","volume":"23","author":"Macer","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib54","first-page":"509","article-title":"Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo-controlled trial","volume":"11","author":"Mikocka-Walus","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.01.027_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0447.1990.tb06443.x","article-title":"Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients","volume":"81","author":"Maes","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1053\/j.gastro.2018.01.027_bib56","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/ard.2008.100008","article-title":"Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis","volume":"68","author":"Hoes","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2018.01.027_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2015.03.016","article-title":"Altered fecal microbiota composition in patients with major depressive disorder","volume":"48","author":"Jiang","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1053\/j.gastro.2018.01.027_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","article-title":"Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat","volume":"82","author":"Kelly","year":"2016","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1053\/j.gastro.2018.01.027_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izy052","article-title":"No significant association between the fecal microbiome and the presence of irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease","author":"Shutkever","year":"2018","journal-title":"Inflamm Bowel Dis"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518300684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518300684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:17:35Z","timestamp":1758035855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508518300684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0016508518300684"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2018.01.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732568175.793550235","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bi-directionality of Brain\u2013Gut Interactions in Patients With Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2018.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}